Credit Suisse’s Myovant Sciences Ltd. MYOV Stock Holding History

Credit Suisse’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$78K	–	4491
2021 Q4	$78K	Buy	+5,000	New	+$95.4K	﹤0.01%	4401

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Suisse's MYOV Position: Q1 2023 in Review

Credit Suisse sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 233,976 shares — an estimated $6.31M sold.

Credit Suisse first reported a position in MYOV in Q2 2017 and held it in 16 quarters. The position peaked at $6.31M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Credit Suisse reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 233,976 Myovant Sciences Ltd. shares in Q1 2023, an estimated $6.31M.
Credit Suisse first reported a position in Myovant Sciences Ltd. in Q2 2017 and held it in 16 quarters.
Credit Suisse's Myovant Sciences Ltd. position peaked at $6.31M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.